glp-1 and cancer risk Can Medications Reduce Breast Risk? Glucagon-like peptide 1 receptor agonists

If you are new to Blum Center, speak with an advisor

Indole-3-carbinol (I3C) and its metabolite DIM exert hormone-modulatory effects by shifting estrogen metabolism from the genotoxic 16-hydroxyestrone pathway toward the less carcinogenic 2-hydroxyestrone pathway, enhancing CYP1A1/1A2 activity, and simultaneously downregulating ER and upregulating ER expression, which together lead to suppression of estrogen-driven proliferation and sensitization of tumours to endocrine therapies (191)

primary-cta How to Access GHK-Cu Through Licensed Providers Eden enables access to licensed healthcare providers who evaluate personal wellness goals and determine whether compounded medications, such as GHK-Cu, may be appropriate

doi: 10.1002/jppr.1897 10